With 0.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.59 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.3499 whereas the lowest price it dropped to was $3.0500. The 52-week range on COSM shows that it touched its highest point at $38.75 and its lowest point at $1.69 during that stretch. Beta for the stock currently stands at 3.15.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of COSM was down-trending over the past week, with a drop of -6.78%, but this was down by -9.20% over a month. Three-month performance dropped to -19.18% while six-month performance fell -61.40%. The stock lost -87.96% in the past year, while it has lost -30.70% so far this year.
Float and Shares Shorts:
At present, 10.62 million COSM shares are outstanding with a float of 8.86 million shares on hand for trading. On May 14, 2023, short shares totaled 0.32 million, which was 3.05% higher than short shares on Apr 13, 2023. In addition to Mr. Grigorios Siokas as the firm’s Chairman & CEO, Mr. Georgios Terzis serves as its Chief Financial Officer.
Through their ownership of 3.34% of COSM’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 2.25% of COSM, in contrast to 2.02% held by mutual funds. Shares owned by individuals account for 10.75%. As the largest shareholder in COSM with 2.52% of the stake, BlackRock Fund Advisors holds 267,797 shares worth 267,797. A second-largest stockholder of COSM, Geode Capital Management LLC, holds 92,318 shares, controlling over 0.87% of the firm’s shares. Sabby Management LLC is the third largest shareholder in COSM, holding 35,006 shares or 0.33% stake. With a 1.27% stake in COSM, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 134,834 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.51% of COSM stock, is the second-largest Mutual Fund holder. It holds 54,096 shares valued at 0.18 million. Fidelity Total Market Index Fund holds 0.15% of the stake in COSM, owning 16,222 shares worth 54668.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, COSM reported revenue of $13.21M and operating income of -$74.36k. The EBITDA in the recently reported quarter was $34.17k and diluted EPS was -$23.25.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for COSM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded COSM stock several times over the past three months with 2 Buys and 0 Sells. In these transactions, 6,712 shares were bought while 0 shares were sold. The number of buy transactions has increased to 8 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 15,441,890 while 0 shares were sold.